← Back to Search

Regenerative Medicine

PRP Injections for Low Back Pain

N/A

Recruiting

Led By Min Ho Chang, MD

Research Sponsored by Womack Army Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult age 18-75 (inclusive)

Predominant area of pain is axial low back pain

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 and 6 months

Awards & highlights

Study Summary

This trial will study a new regenerative medicine treatment, PRP, to help with low back pain for military personnel. PRP is a minimally invasive treatment that may help improve pain and function without causing destructive lesions or worsening degenerative joints.

Who is the study for?

This trial is for military personnel aged 18-75 with chronic low back pain lasting over 3 months, who have not had recent spinal interventions or lumbar fusion, and are not on high opioid doses. Participants must speak English, be DEERS eligible, and able to consent. They should have a positive response to a diagnostic block injection but can't join if they're pregnant, moving soon, or have certain medical conditions.Check my eligibility

What is being tested?

The study tests Platelet Rich Plasma (PRP) injections as a treatment for lower back pain by comparing its effectiveness against placebo control injections. PRP aims to preserve joint structures and improve pain without causing further damage. The goal is better rehabilitation outcomes and return-to-duty status for military personnel.See study design

What are the potential side effects?

While the trial description does not specify side effects of PRP injections in detail, common ones may include temporary increased pain at the injection site, bleeding or bruising, tissue damage or infection risks due to needle insertion.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 75 years old.

Select...

My main pain area is in my lower back.

Select...

I have had lower back pain for over 3 months.

Select...

My daily pain level averages 4 out of 10 or higher.

Select...

I felt significant pain relief after a diagnostic nerve block injection.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Defense Veteran Pain Rating Scale+ Supplemental Questions (DVPRS)

Global Rate of Change (GROC)

Numeric Rating Scale (NRS)

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Platelet Rich Plasma injection to lumbar facet jointExperimental Treatment1 Intervention

Platelet Rich Plasma injection to lumbar facet joint

Group II: Placebo injection to lumbar facet jointPlacebo Group1 Intervention

Placebo injection to lumbar facet joint

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

The Geneva FoundationOTHER

30 Previous Clinical Trials

12,224 Total Patients Enrolled

3 Trials studying Low Back Pain

300 Patients Enrolled for Low Back Pain

Womack Army Medical CenterLead Sponsor

18 Previous Clinical Trials

16,125 Total Patients Enrolled

Uniformed Services University of the Health SciencesFED

116 Previous Clinical Trials

91,246 Total Patients Enrolled

2 Trials studying Low Back Pain

571 Patients Enrolled for Low Back Pain

Media Library

Platelet Rich Plasma (Regenerative Medicine) Clinical Trial Eligibility Overview. Trial Name: NCT04822753 — N/A

Low Back Pain Research Study Groups: Platelet Rich Plasma injection to lumbar facet joint, Placebo injection to lumbar facet joint

Low Back Pain Clinical Trial 2023: Platelet Rich Plasma Highlights & Side Effects. Trial Name: NCT04822753 — N/A

Platelet Rich Plasma (Regenerative Medicine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04822753 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are taking part in this experiment?

"Affirmative. Clinicaltrials.gov conveys that this medical examination is actively searching for participants, which began on September 29th 2021 and was recently updated in October 25th 2021. 170 individuals are required at 1 trial site to properly conduct the study."

Answered by AI

Is the demographics for this trial extending beyond thirty years of age?

"The eligibility criteria for this medical trial requires potential participants to be over 18 years of age and under 75."

Answered by AI

Who qualifies to partake in this clinical research?

"The enrollment requirements for this clinical trial stipulate that patients must be between 18 and 75 years old. This medical experiment is aiming to recruit a total of 170 subjects."

Answered by AI

Are participants currently being accepted for this experiment?

"Affirmative. Clinicaltrials.gov confirms that this clinical trial, initially posted on September 29th 2021 is currently seeking volunteers. A total of 170 patients are needed for the research taking place at 1 location."

Answered by AI